Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Organon & Co. Common Stock (NY:OGN)

6.625 -0.085 (-1.26%)
Streaming Delayed Price Updated: 10:50 AM EST, Nov 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Organon & Co. Common Stock

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Organon Reports Results for the Third Quarter Ended September 30, 2023
From Organon & Co.
Via Business Wire
Organon and Sempre Health Announce Collaboration on New Service to Help Eligible Patients Save Money and Stay on Their Medication as Prescribed
From Organon & Co.
Via Business Wire
A Look Into Healthcare Sector Value Stocks
 
Via Benzinga
Organon To Report Third Quarter Results and Host Conference Call on November 2, 2023
From Organon & Co.
Via Business Wire
Lululemon Athletica Races to New High with S&P 500 Entry
Lululemon's stock soared 10.31%, its best level since late 2021, upon joining the S&P 500, replacing Activision Blizzard. The change is effective October 18. 
Via MarketBeat
Topics Stocks
Lululemon Athletica To Join S&P 500 Index; LULU Stock Flashes Buy Signal
The yoga retailer will join the index before Wednesday's open. 
Via Investor's Business Daily
Topics Stocks
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Organon Recognized on Fortune’s 2023 Change the World List for Leadership in Expanding Access to Contraceptive Choice
From Organon & Co.
Via Business Wire
5 Value Stocks To Watch In The Healthcare Sector
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2023
 
Via Benzinga
First Real-World Observational Study of the JADA® System, a Medical Device to Control Postpartum Hemorrhage (PPH), Published in ACOG’s Obstetrics & Gynecology
From Organon & Co.
Via Business Wire
3 Pharmaceutical Stocks That Are Too Cheap to Ignore
Viatris, GSK, and Organon are all trading at less than 7 times earnings. 
Via The Motley Fool
Stock Analysis: Organon & Co.
Organon & Co. sells its products to drug wholesalers, retailers, hospitals, pharmacies, clinics, government agencies, and other institutions worldwide. 
Via Talk Markets
Organon Bolsters Research & Development Expertise with Two Leadership Appointments
From Organon & Co.
Via Business Wire
3 Undervalued Healthcare Stocks In 2023
These 3 undervalued healthcare stocks in 2023 are attractive today for their attractive valuations and total return potential. 
Via Talk Markets
A Look Into Healthcare Sector Value Stocks
 
Via Benzinga
Organon Reports Results for the Second Quarter Ended June 30, 2023
From Organon & Co.
Via Business Wire
5 Value Stocks In The Healthcare Sector
 
Via Benzinga
Samsung Bioepis & Organon Announce Topline Results from Interchangeability Study of SB5 Humira Biosimilar
From Samsung Bioepis
Via GlobeNewswire
Overview Of Value Stocks In The Healthcare Sector
 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Need an Extra $4,000 in Dividends Each Year? Invest $68,000 in These 3 Stocks.
These stocks can significantly bolster your income. 
Via The Motley Fool
Datadog, IQVIA, Organon And An Oilfield Services Giant Rolling Out An AI Platform: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Jason Snipe of Odyssey Capital Advisors said he likes IQVIA Holdings Inc. (NYSE: IQV) 
Via Benzinga
Organon To Report Second Quarter Results and Host Conference Call on August 8, 2023
From Organon & Co.
Via Business Wire
REPEAT/Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA™ (adalimumab-bwwd) in Multiple Presentations Consistent with Originator
From Organon
Via Business Wire
3 S&P 500 Stocks to Own for the Next 50 Years
These three S&P 500 companies all buy and hold stocks for the next 50 years or more because they operate in attractive industries. 
Via InvestorPlace
Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA™ (adalimumab-bwwd) in Multiple Presentations Consistent with Originator
From Organon & Co.
Via Business Wire
Want $5,000 in Annual Dividend Income? Invest in These 3 Stocks
These stocks are down more than 5% this year, and now may be a good time to add them to your portfolio. 
Via The Motley Fool
Organon Publishes FY2022 ESG Report Showcasing Progress Toward Global Sustainability Goals
From Organon & Co.
Via Business Wire
Check Out 3 Health Care Stocks With Over 4% Dividend Yields From Wall Street's Most Accurate Analysts
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.